Inari Medical, Inc. (NARI) financial statements (2022 and earlier)

Company profile

Business Address 6001 OAK CANYON, SUITE 100
IRVINE, CA 92618
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:176,10085,011
Cash and cash equivalents92,752 
Short-term investments83,34849,981
Other undisclosed cash, cash equivalents, and short-term investments 35,030
Restricted cash and investments 50
Receivables42,35128,008
Inventory, net of allowances, customer advances and progress billings21,05310,597
Inventory21,05310,597
Capitalized contract cost 228
Other undisclosed current assets5,69481,779
Total current assets:245,198205,673
Noncurrent Assets
Operating lease, right-of-use asset44,909 
Property, plant and equipment16,4717,498
Long-term investments and receivables3,983 
Long-term investments3,983 
Restricted cash and investments 338
Other undisclosed noncurrent assets981583
Total noncurrent assets:66,3448,419
TOTAL ASSETS:311,542214,092
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities30,97411,245
Accounts payable6,5413,047
Employee-related liabilities24,4338,198
Other undisclosed current liabilities11,5392,593
Total current liabilities:42,51313,838
Noncurrent Liabilities
Long-term debt and lease obligation28,404 
Operating lease, liability28,404 
Liabilities, other than long-term debt1,416 
Other liabilities1,416 
Total noncurrent liabilities:29,820 
Total liabilities:72,33313,838
Stockholders' equity
Stockholders' equity attributable to parent239,209200,254
Common stock5049
Additional paid in capital257,144227,624
Accumulated other comprehensive income (loss)(402)4
Accumulated deficit(17,583)(27,423)
Total stockholders' equity:239,209200,254
TOTAL LIABILITIES AND EQUITY:311,542214,092

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
Revenues276,984139,670
Cost of revenue
(Cost of Goods and Services Sold)
(24,757)(13,106)
Gross profit:252,227126,564
Operating expenses(241,383)(108,145)
Operating income:10,84418,419
Nonoperating expense
(Other Nonoperating expense)
(159)(4,630)
Interest and debt expense(295)(648)
Income from continuing operations before equity method investments, income taxes:10,39013,141
Other undisclosed income from continuing operations before income taxes295648
Income from continuing operations before income taxes:10,68513,789
Income tax expense(845) 
Net income available to common stockholders, diluted:9,84013,789

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
Net income:9,84013,789
Other comprehensive loss(406) 
Comprehensive income:9,43413,789
Other undisclosed comprehensive income, net of tax, attributable to parent 4
Comprehensive income, net of tax, attributable to parent:9,43413,793

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: